Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 0.8x - 0.9x | 0.9x |
| Historical Pb Multiple | 0.8x - 1.5x | 1.0x |
| Fair Value | €80.31 - €88.76 | €84.53 |
| Upside | 18.8% - 31.3% | 25.0% |
| Benchmarks | - | Full Ticker |
| Syensqo SA/NV | - | DUSE:2NF |
| Umicore SA | - | DB:NVJP |
| Evonik Industries AG | - | DB:EVK |
| LANXESS Aktiengesellschaft | - | DB:LXS |
| Novonesis A/S | - | DB:NZM2 |
| Arkema S.A. | - | DB:V1S |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 2NF | NVJP | EVK | LXS | NZM2 | V1S | |||
| DUSE:2NF | DB:NVJP | DB:EVK | DB:LXS | DB:NZM2 | DB:V1S | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | -21.7% | NM- | -6.2% | -7.2% | ||
| 3Y CAGR | NM- | NM- | -33.3% | NM- | -10.2% | -36.1% | ||
| Latest Twelve Months | -1450.0% | -484.3% | 184.0% | 85.7% | 37.2% | -11.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 2.2% | -0.1% | 2.9% | 5.0% | 17.6% | 7.0% | ||
| Prior Fiscal Year | 2.7% | 2.1% | -3.0% | -12.6% | 16.9% | 4.2% | ||
| Latest Fiscal Year | -0.1% | -10.0% | 1.5% | -2.8% | 8.0% | 3.5% | ||
| Latest Twelve Months | -1.6% | -10.0% | 2.0% | -2.1% | 11.3% | 3.2% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 5.5% | 2.6% | 3.9% | 3.3% | 22.7% | 10.5% | ||
| Prior Fiscal Year | 3.1% | 10.7% | -4.7% | -18.9% | 21.7% | 5.5% | ||
| Latest Twelve Months | -1.4% | -52.9% | 3.3% | -3.1% | 7.0% | 4.1% | ||
| Next Fiscal Year | 7.1% | 12.2% | 8.2% | 3.3% | 8.2% | 7.3% | ||
| Two Fiscal Years Forward | 8.3% | 12.3% | 8.6% | 3.8% | 8.5% | 8.5% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 1.0x | 0.1x | 0.6x | 0.4x | 7.0x | 0.5x | ||
| Price / LTM EPS | -62.3x | -1.4x | 31.5x | -17.3x | 61.7x | 16.6x | ||
| Price / Book | 0.9x | 1.1x | 1.0x | 0.5x | 2.5x | 0.7x | ||
| Price / Fwd Book | 0.7x | 1.0x | 1.0x | 0.5x | 2.4x | 0.7x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 0.5x | 1.0x | 2.5x | |||||
| Historical P/B Ratio | 0.8x | 1.0x | 1.5x | |||||
| Selected P/B Multiple | 0.8x | 0.9x | 0.9x | |||||
| (x) Book Value | 7,368 | 7,368 | 7,368 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 2NF | NVJP | EVK | LXS | NZM2 | V1S | |
| Value of Common Equity | 5,058 | 2,032 | 9,469 | 2,318 | 28,367 | 5,088 | |
| (/) Shares Outstanding | 89.6 | 240.5 | 466.0 | 86.3 | 465.8 | 75.3 | |
| Implied Stock Price | 56.45 | 8.45 | 20.32 | 26.84 | 60.90 | 67.60 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 56.45 | 8.45 | 20.32 | 26.84 | 60.90 | 67.60 | |
| Trading Currency | EUR | EUR | EUR | EUR | EUR | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |